Blog

Pashtoon Kasi: Our paper with more than 10,000 accesses ranks at N1 in Oncogene Journal

Photo from Pashtoon Kasi / X

Dec 20, 2023, 09:57

Pashtoon Kasi: Our paper with more than 10,000 accesses ranks at N1 in Oncogene Journal

Pashtoon Kasi, the Director for Colorectal Cancer Research at Weill Cornell Medicine, shared on X:

“Our paper with more than 10,000 accesses ranks at N1 in Oncogene Journal.

Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient (pMMR/MSS) colorectal cancer.

Link: https://nature.com/articles/s41388-023-02835-y

GI24 will present full NEST-1 cohort.”

Source: Pashtoon Kasi / X

Balstilimab botensilimab botensilimab plus balstilimab cancer colorectal cancer Colorectal Cancer Research immunotherapy immunotherapy for colorectal cancer mismatch repair proficient Neoadjuvant botensilimab plus balstilimab OncoDaily Oncogene journal Oncology Pashtoon Kasi Weill Cornell Medicine

Oncologist Near Me – Giuseppe Curigliano: A Prominent Specialist in Breast Cancer Clinical Trials and Research

FDA Approves T-DXd for HR+, HER2-Low/Ultralow Breast Cancer Treatment

Oncologist Near Me - Hagop Kantarjian: A Legend in Leukemia Research and Treatment

New Paper Alert: Botensilimab and Balstilimab in Relapsed/Refractory Metastatic Sarcomas

Best of ASCOGI25